Selected life-science and specialty-product businesses may be considered through available specialty markets. Manufacturing, labeling, distribution and intended use each shape the account.
Product and role
Describe product type, intended use, ingredients, formulation and your manufacturing, importing, distributing or brand-owner role.
Quality and testing
Explain manufacturing controls, quality assurance, testing, outside laboratories and Certificates of Analysis.
Labeling and regulation
Provide labeling controls, regulatory jurisdictions and applicable licenses.
Supply chain
Identify third-party manufacturing, distribution and vendor responsibilities.
Adverse events and recalls
Explain prior complaints, adverse events, recalls and claims, together with response procedures.
Cannabis-related operations
Where legally permitted and market-eligible, describe operation type, extraction, processing, testing, storage and security.
See the whole account.
Products & liability
Nutraceuticals
Selected dietary supplements, vitamins, herbs, protein and energy products, subject to ingredients and labeling review.
General liability and products-completed operations, including products-only options and $1 million / $2 million limits.
Policy structure & extensions
Occurrence & claims-made
General liability occurrence and products claims-made structures; claims-made general liability may also be available.
Contract requirements
Selected additional insured, primary/noncontributory, waiver of subrogation and worldwide options.
Additional extensions
Employee benefits liability, hired/non-owned auto and security-breach expense options vary by offer. Confirm each endorsement.
The placement desk
Ingredients, claims and controls matter.
Explain ingredients, labeling claims, testing and traceability. Selected cannabis-related operations require jurisdiction and market review. The current focus does not establish clinical-trial, biotechnology or other unlisted product capacity.
Reviewed 2026-09-28 · Review through 2026-12-28 · Revision 1
At a glance
Territory
Confirm with underwriting
Submission route
Manual review
Values & exposures
Sales by product and territory (USD / stated period)
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Ingredients, claims and intended use
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Manufacturing/private-label role
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Testing, traceability and distribution controls
Confirm with underwriting
Provide account details; program thresholds require confirmation.
What fits / What needs review
Supplements & nutraceuticals
Manufacturers & processors
Brand owners & distributors
Selected cannabis-related risks
Explain ingredients, labeling claims, testing and traceability. Selected cannabis-related operations require jurisdiction and market review. The current focus does not establish clinical-trial, biotechnology or other unlisted product capacity.
Applications & documents
Completed ACORD applications
Confirm the selected program’s forms, history period and valuation age.
Required supplemental applications
Confirm the selected program’s forms, history period and valuation age.
Currently valued loss runs
Confirm the selected program’s forms, history period and valuation age.
Preparation guidance, not an eligibility decision, account quote or coverage confirmation. Confirm applicable terms and required forms with underwriting.
Osprey approved editorial guidance · 28 September 2026
Reviewed 2026-09-28 · Review through 2026-12-28 · Revision 1
At a glance
Territory
Confirm with underwriting
Submission route
Manual review
Values & exposures
Sales by product and territory (USD / stated period)
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Ingredients, claims and intended use
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Manufacturing/private-label role
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Testing, traceability and distribution controls
Confirm with underwriting
Provide account details; program thresholds require confirmation.
What fits / What needs review
Supplements & nutraceuticals
Manufacturers & processors
Brand owners & distributors
Selected cannabis-related risks
Explain ingredients, labeling claims, testing and traceability. Selected cannabis-related operations require jurisdiction and market review. The current focus does not establish clinical-trial, biotechnology or other unlisted product capacity.
Applications & documents
Completed ACORD applications
Confirm the selected program’s forms, history period and valuation age.
Required supplemental applications
Confirm the selected program’s forms, history period and valuation age.
Currently valued loss runs
Confirm the selected program’s forms, history period and valuation age.
Preparation guidance, not an eligibility decision, account quote or coverage confirmation. Confirm applicable terms and required forms with underwriting.
Osprey approved editorial guidance · 28 September 2026
Reviewed 2026-09-28 · Review through 2026-12-28 · Revision 1
At a glance
Territory
Confirm with underwriting
Submission route
Manual review
Values & exposures
Sales by product and territory (USD / stated period)
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Ingredients, claims and intended use
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Manufacturing/private-label role
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Testing, traceability and distribution controls
Confirm with underwriting
Provide account details; program thresholds require confirmation.
What fits / What needs review
Supplements & nutraceuticals
Manufacturers & processors
Brand owners & distributors
Selected cannabis-related risks
Explain ingredients, labeling claims, testing and traceability. Selected cannabis-related operations require jurisdiction and market review. The current focus does not establish clinical-trial, biotechnology or other unlisted product capacity.
Applications & documents
Completed ACORD applications
Confirm the selected program’s forms, history period and valuation age.
Required supplemental applications
Confirm the selected program’s forms, history period and valuation age.
Currently valued loss runs
Confirm the selected program’s forms, history period and valuation age.
Preparation guidance, not an eligibility decision, account quote or coverage confirmation. Confirm applicable terms and required forms with underwriting.
Osprey approved editorial guidance · 28 September 2026
Reviewed 2026-09-28 · Review through 2026-12-28 · Revision 1
At a glance
Territory
Confirm with underwriting
Submission route
Manual review
Values & exposures
Sales by product and territory (USD / stated period)
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Ingredients, claims and intended use
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Manufacturing/private-label role
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Testing, traceability and distribution controls
Confirm with underwriting
Provide account details; program thresholds require confirmation.
What fits / What needs review
Supplements & nutraceuticals
Manufacturers & processors
Brand owners & distributors
Selected cannabis-related risks
Explain ingredients, labeling claims, testing and traceability. Selected cannabis-related operations require jurisdiction and market review. The current focus does not establish clinical-trial, biotechnology or other unlisted product capacity.
Applications & documents
Completed ACORD applications
Confirm the selected program’s forms, history period and valuation age.
Required supplemental applications
Confirm the selected program’s forms, history period and valuation age.
Currently valued loss runs
Confirm the selected program’s forms, history period and valuation age.
Preparation guidance, not an eligibility decision, account quote or coverage confirmation. Confirm applicable terms and required forms with underwriting.
Osprey approved editorial guidance · 28 September 2026
Reviewed 2026-09-28 · Review through 2026-12-28 · Revision 1
At a glance
Territory
Confirm with underwriting
Submission route
Manual review
Values & exposures
Sales by product and territory (USD / stated period)
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Ingredients, claims and intended use
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Manufacturing/private-label role
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Testing, traceability and distribution controls
Confirm with underwriting
Provide account details; program thresholds require confirmation.
What fits / What needs review
Supplements & nutraceuticals
Manufacturers & processors
Brand owners & distributors
Selected cannabis-related risks
Explain ingredients, labeling claims, testing and traceability. Selected cannabis-related operations require jurisdiction and market review. The current focus does not establish clinical-trial, biotechnology or other unlisted product capacity.
Applications & documents
Completed ACORD applications
Confirm the selected program’s forms, history period and valuation age.
Required supplemental applications
Confirm the selected program’s forms, history period and valuation age.
Currently valued loss runs
Confirm the selected program’s forms, history period and valuation age.
Preparation guidance, not an eligibility decision, account quote or coverage confirmation. Confirm applicable terms and required forms with underwriting.
Osprey approved editorial guidance · 28 September 2026
Reviewed 2026-09-28 · Review through 2026-12-28 · Revision 1
At a glance
Territory
Confirm with underwriting
Submission route
Manual review
Values & exposures
Sales by product and territory (USD / stated period)
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Ingredients, claims and intended use
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Manufacturing/private-label role
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Testing, traceability and distribution controls
Confirm with underwriting
Provide account details; program thresholds require confirmation.
What fits / What needs review
Supplements & nutraceuticals
Manufacturers & processors
Brand owners & distributors
Selected cannabis-related risks
Explain ingredients, labeling claims, testing and traceability. Selected cannabis-related operations require jurisdiction and market review. The current focus does not establish clinical-trial, biotechnology or other unlisted product capacity.
Applications & documents
Completed ACORD applications
Confirm the selected program’s forms, history period and valuation age.
Required supplemental applications
Confirm the selected program’s forms, history period and valuation age.
Currently valued loss runs
Confirm the selected program’s forms, history period and valuation age.
Preparation guidance, not an eligibility decision, account quote or coverage confirmation. Confirm applicable terms and required forms with underwriting.
Osprey approved editorial guidance · 28 September 2026
Reviewed 2026-09-28 · Review through 2026-12-28 · Revision 1
At a glance
Territory
Confirm with underwriting
Submission route
Manual review
Values & exposures
Sales by product and territory (USD / stated period)
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Ingredients, claims and intended use
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Manufacturing/private-label role
Confirm with underwriting
Provide account details; program thresholds require confirmation.
Testing, traceability and distribution controls
Confirm with underwriting
Provide account details; program thresholds require confirmation.
What fits / What needs review
Supplements & nutraceuticals
Manufacturers & processors
Brand owners & distributors
Selected cannabis-related risks
Explain ingredients, labeling claims, testing and traceability. Selected cannabis-related operations require jurisdiction and market review. The current focus does not establish clinical-trial, biotechnology or other unlisted product capacity.
Applications & documents
Completed ACORD applications
Confirm the selected program’s forms, history period and valuation age.
Required supplemental applications
Confirm the selected program’s forms, history period and valuation age.
Currently valued loss runs
Confirm the selected program’s forms, history period and valuation age.
Preparation guidance, not an eligibility decision, account quote or coverage confirmation. Confirm applicable terms and required forms with underwriting.
Osprey approved editorial guidance · 28 September 2026
Start with the product. Build the submission.
Share the account. Start the placement conversation.